Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
BRIEF-AB Science says DSMB recommends continuation of phase 3 masitinib study
PI(3,5)P2 biosynthesis regulates oligodendrocyte differentiation by intrinsic and extrinsic mechanisms.
Fingolimod-A sphingosine-like molecule inhibits vesicle mobility and secretion in astrocytes.
Lights and shadows of cyclophosphamide in the treatment of multiple sclerosis.
Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod.
Late relapse of non-seminomatous testicular cancer during treatment of multiple sclerosis with interferon β-1a: A case report.
[Nicolau syndrome after administration of glatiramer acetate].
Epigenetic mechanisms in multiple sclerosis and the major histocompatibility complex (MHC).
Meanings, motivations, and strategies for engaging in physical activity among women with multiple sclerosis.
[Infections and fingolimod].
Higher Relative Risk for Multiple Sclerosis in a Pediatric and Adolescent Diabetes Population: Analysis From DPV Data Base.
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome.
Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats.
The Relative Importance of Baseline Pain, Fatigue, Sleep and Physical Activity: Predicting Change in Depression in Adults with Multiple Sclerosis.
Fingolimod phosphate promotes the neuroprotective effects of microglia.
The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis.
A urinary test procedure for identification of cannabidiol in patients undergoing medical therapy with marijuana.
CD8(+) T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease.
Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy.
Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.
Glatiramer acetate does not protect from acute ischemic stroke in mice.
Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder.
Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis.
Increased Serum Brain-derived Neurotrophic Factor in Multiple Sclerosis Patients on Interferon-β and Its Impact on Functional Abilities.
Identification of the LDL Receptor-Related Protein-1 Interactome in Central Nervous System myelin suggests a role in the clearance of necrotic cell debris.
Pages
« first
‹ previous
…
88
89
90
91
92
93
94
95
96
…
next ›
last »